↓ Skip to main content

Dove Medical Press

Article Metrics

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, January 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
11 tweeters

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
15 Mendeley
Title
Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
Published in
International Journal of Chronic Obstructive Pulmonary Disease, January 2016
DOI 10.2147/copd.s78000
Pubmed ID
Authors

Maria Gabriella Matera, Alessandro Sanduzzi, Mario Cazzola

Abstract

Co-administration of a long-acting β2-agonist and a long acting muscarinic antagonist produces superior bronchodilation compared with their individual effects. Our preclinical data indicated that combining aclidinium bromide (ACLI) and formoterol fumarate (FORM) provides synergistic benefit on smooth muscle relaxation of both large and small human airways. Data from more than 2,000 patients in eleven clinical trials documented that ACLI/FORM, a twice-daily fixed-dose combination, produces a greater degree of bronchodilation than ACLI or FORM monotherapy alone and is safe and well tolerated. Two large key trials have shown that there is a benefit in using ACLI/FORM when the clinical target is the variability of symptoms and mainly nighttime and/or early morning symptoms. ACLI/FORM is the only long acting muscarinic antagonist/long acting β2-agonist fixed-dose combination that has been studied for this therapeutic indication.

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 7%
Unknown 14 93%

Demographic breakdown

Readers by professional status Count As %
Other 4 27%
Student > Master 4 27%
Researcher 2 13%
Student > Bachelor 2 13%
Professor 1 7%
Other 1 7%
Unknown 1 7%
Readers by discipline Count As %
Medicine and Dentistry 7 47%
Pharmacology, Toxicology and Pharmaceutical Science 4 27%
Economics, Econometrics and Finance 1 7%
Unknown 3 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2016.
All research outputs
#2,840,785
of 14,965,031 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#389
of 1,795 outputs
Outputs of similar age
#75,989
of 366,619 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#13
of 54 outputs
Altmetric has tracked 14,965,031 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,795 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,619 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.